Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)
Cinieri, Saverio, Chan, Arlene, Altundag, Kadri, Vandebroek, Ann, Tubiana-Mathieu, Nicole, Barnadas, Agusti, Dodyk, Patricia, Lazzarelli, Silvia, Botha, Michiel, Rauch, Daniel, Khasanov, Rustem, Slabber, Coenraad Frederik, Bougnoux, Philippe, Cardenas, Jesus S., Castellanos Diez, Javier, Schmidt, Marcus, Godes, Maria Jose, Chen, Dar-Ren, Villanova, Gustavo, Coskun, Ugur
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article